Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06291922 · ClinicalTrials.gov registry record · NA

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

A NA study of Heart Failure, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
4
Study locations

NCT06291922: Recruiting NA study of Heart Failure, sponsored by University of Pennsylvania.

NCT06291922 is a NA study of Heart Failure that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06291922, a NA study of Heart Failure, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Exercise Intervention

Study Locations (4)

Michigan

  • Henry Ford Health - Detroit

Ohio

  • Cleveland Clinic Foundation - Cleveland

Pennsylvania

  • University of Pennsylvania - Philadelphia

Utah

  • University of Utah Health - Salt Lake City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-08-14
Est. Completion 2028-06-30
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT06291922

The ClinicalTrials.gov registry entry for NCT06291922 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT06291922 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Michigan, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06291922 about?

NCT06291922 is a clinical study titled "Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation". The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers wi...

What is the current status of trial NCT06291922?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-14. Estimated completion is 2028-06-30.

What conditions does trial NCT06291922 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT06291922?

The interventions under investigation include: Usual Care (BEHAVIORAL), Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06291922?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06291922 being conducted?

This trial has 4 study locations across Michigan, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.